Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Consolidated Statements Of Cash Flows [Abstract]
Net income	$ 738	$ 718
Adjustments to reconcile net loss to net cash from operating activities:
Provision for loan losses	210	150
Depreciation	107	104
Amortization, net	(25)	(7)
Net loss on sales of securities		12
Originations of loans held for sale	(7,485)	(28,193)
Proceeds from sale of loans held for sale	5,689	30,833
Net gains on sales of loans	(51)	(293)
Gain on sale of foreclosed assets	(4)
Earnings on bank owned life insurance	(66)	(65)
Stock-based compensation expense	59	71
Change in deferred income taxes	(41)
Net change in:
Accrued interest receivable and other assets	1,211	594
Accrued interest payable and other liabilities	(125)	(325)
Net cash from operating activities	217	3,599
Cash flows from investing activities
Net increase in interest-bearing deposits in other financial institutions	(100)
Available-for-sale securities:
Maturities, prepayments and calls	148	1,280
Loan originations and payments, net	(27,142)	(30,661)
Proceeds from the sale of loans	1,124	2,663
Additions to premises and equipment	(28)	(18)
Proceeds from the sale of foreclosed assets	200
Net cash used by investing activities	(25,798)	(26,736)
Cash flows from financing activities
Net change in deposits	5,555	23,719
Proceeds from FHLB advances	33,000	2,500
Repayments on FHLB advances	(25,000)	(2,500)
Net change in advances by borrowers for taxes and insurance	(458)	(121)
Cash dividends paid on Series B preferred stock	(375)	(375)
Purchase of treasury shares	(29)
Net cash from financing activities	12,693	23,223
Net change in cash and cash equivalents	(12,888)	86
Beginning cash and cash equivalents	25,895	28,207
Ending cash and cash equivalents	13,007	28,293
Supplemental cash flow information:
Interest paid	1,419	1,242
Supplemental noncash disclosures:
Loans issued to finance the sale of repossessed assets	1,440
Loans transferred from held for sale to portfolio		834
Loans transferred from portfolio to held for sale		175
Dividends payable on Series B preferred stock	$ 187	$ 187